BioPharma « Terug naar discussie overzicht

Transmeta Corporation (TMTA)

5.364 Posts, Pagina: « 1 2 3 4 5 6 ... 213 214 215 216 217 218 219 220 221 222 223 ... 265 266 267 268 269 » | Laatste
[verwijderd]
0
Als ik een kleine positie had dan was ik ook vol gebleven. Maar mijn portefeuille bestond voor meer dan 60% uit TMTA. Dus ik moest wel wat verkopen, anders is het een te groot risico.
[verwijderd]
0

quote:

M.A.D.W. schreef:

Als ik een kleine positie had dan was ik ook vol gebleven. Maar mijn portefeuille bestond voor meer dan 60% uit TMTA. Dus ik moest wel wat verkopen, anders is het een te groot risico.
same here

nog steeds dankbaar voor je draadje indertijd
alle gtcb verlies nu meer dan goedgemaakt
tenzij ie morgen dik duikelt
maar verwacht ook meer stijging dan daling
Salieman
0
quote:

Compugreen schreef:

16:03:03.877 B 392 1.6400
16:02:57.782 S 443 1.6300
15:59:49.601 S 1,300 1.6500
15:59:49.601 S 500 1.6500
15:59:39.996 B 500 1.6500
15:59:39.996 B 500 1.6500
15:59:39.996 B 400 1.6500
15:59:39.996 B 1,000 1.6500

15:59:49.601 S 500 1.6500
die zijn van mij...
hoe is het nu in godsnaam mogelijk dat ze niet alle 1700 verkocht zijn..... tsss
Wees blij!! Goed PB uit

biz.yahoo.com/bw/051108/2005110800609...
[verwijderd]
0
quote:

crackedtooth schreef:

[quote=positivo73]
Ik heb mijn 6,5K gewoon gehouden, is vergeleken met de rest van mijn porto wel veel, maar ik heb vertrouwen. ik heb ze overigens gemiddeld voor 1,24,.
Ik kan haast niet wachten.
m.v..g.Willem
[/quote]

laat gekocht dan of juist erg vroeg, maar geef je idd meer speling

jij idee hoe lang presentatie zal zijn?
10min?..20?

Minuutje of 2 ??
"Goodafternoon gentlemen. We made an earning of 40 million bucks last Q, and a profit per share of $0.08... Autographs after the buffet... Thank you !"
positivo73
0
er wordt nou flink gehandeld op dit moment, dit moet zeker goed komen als ik de kooporders zo zie.
[verwijderd]
0
Highlights for the Third Quarter 2005

Net revenue of $27.9 million
Net income of $10.1 million, or $0.05 per share
Positive cash flow from operations of $9.5 million
Cash balance of $56.9 million at September 30, 2005
Deferred income of $6.0 million
Engineering services projects with Sony and Microsoft continue to progress well
Business
[verwijderd]
0
Transmeta Reports Revenue of $27.9 Million and Positive Cash Flow from Operations for Q3 2005
Tuesday November 8, 4:10 pm ET
Raises Cash Guidance to $53 Million at 2005 Fiscal Year End Guides to Revenue of $71 Million to $72 Million for Full Year 2005

SANTA CLARA, Calif.--(BUSINESS WIRE)--Nov. 8, 2005--Transmeta Corporation (Nasdaq:TMTA - News), the leader in efficient computing technologies, today announced financial results for the third quarter ended September 30, 2005.
Highlights for the Third Quarter 2005

Net revenue of $27.9 million
Net income of $10.1 million, or $0.05 per share
Positive cash flow from operations of $9.5 million
Cash balance of $56.9 million at September 30, 2005
Deferred income of $6.0 million
Engineering services projects with Sony and Microsoft continue to progress well
Business Update

"We are pleased with our results as they reflect the early success of our modified business model," commented Arthur L. Swift, president and CEO. "Our continuing goal is to drive Transmeta's technology into high volume market segments by leveraging licensing, customized processor development, and synergistic engineering services. As an early innovator in the fields of microprocessor design and power reduction for leading edge chips, as well as a pioneer in addressing the challenge of power leakage, we have a solid technology base on which to build a sustainable competitive advantage. This year, we will have successfully transformed our business, and as we look to 2006, we are well positioned to capitalize on our solid financial progress and key strategic customer relationships."

Net revenue for the third quarter of 2005 was $27.9 million, compared to $24.7 million in the second quarter of 2005, and $7.0 million in the third quarter of 2004. Net revenue in the third quarter comprised $9.6 million of license revenue, $10.3 million of service revenue and $7.9 million of product revenue. This compares with $10.0 million of license revenue, $7.6 million of service revenue, and $7.1 million of product revenue in the second quarter of 2005. The product revenue reflects end-of-life (EOL) product sales as well as customer product programs which have reached or are reaching the end of their respective product life. In addition, the Company reported deferred income of $6.0 million as of September 30, 2005, as compared to $15.5 million for the second quarter of 2005.

The Company reported gross margin of 99.5% for the license business, 41.6% for the service business and 72.7% for the product business. On a consolidated basis, the Company's gross margin was 70.5% for the 2005 third quarter, compared to 67.1% for the second quarter of 2005, and a negative 62.2% for the third quarter of 2004.

The Company's net income for the third quarter of 2005 was $10.1 million, or $0.05 per share compared with a net income of $6.8 million, or $0.04 per share in the second quarter of 2005, and a net loss of $28.6 million, or a loss of $0.16 per share in the third quarter of 2004.

The Company had positive cash flow from operations of $9.5 million in the third quarter of 2005, as compared to positive cash flow of $4.8 million in the second quarter of 2005 and negative cash flow of $21.2 million in the third quarter of 2004. The Company's cash, cash equivalents and short term investments at September 30, 2005 totaled $56.9 million.

"Our licensing and services businesses, with their varying times to revenue recognition, coupled with our present high degree of customer concentration, can result in a variable revenue profile from quarter to quarter," continued Swift. "Looking forward, our goal is to generate new sources of revenue in 2006, including new licensees for our LongRun2 technologies, our first royalties from our previous LongRun2 licensees, and new revenues from specialized versions of our 90 nanometer Efficeon products."

Guidance

For the 2005 fourth quarter and FYE 2005, we expect:

Positive operating cash flow of $6.0 to $6.5 million in the second half of 2005, increased from prior guidance of breakeven cash flow for the second half
Fourth quarter negative operating cash flow of $3.0 to $3.5 million
FYE 2005 year end cash of $53.0 million, increased from prior guidance of $47.0 million
Fourth quarter total revenue of $12.0 to $13.0 million
Fourth quarter net loss of $5.4 to $5.9 million, or a loss of $0.03 per share
"In the third quarter, we continued to build on the operational and financial success of the second quarter, and we expect to exceed our stated key objective of achieving break-even or better cash flow from operations for the second half of 2005," commented Mark R. Kent, chief financial officer. "For the full year, we are expecting revenues of at least $71 million, which includes product revenue of approximately $24 million. This product revenue includes EOL and legacy customer sales which we expect to substantially conclude this year."

"Looking forward, we expect to replace this transitioning product revenue with new revenue from licensing, services, and our specialized 90 nanometer Efficeon product business," continued Kent. "As we move into next year, we expect to continue growing our Sony services business. In addition, we expect to achieve key program milestones and the recognition of related revenue for a significant development services contract in the first half of 2006."

Conference Call

As previously announced, Transmeta's management will host a conference call today at 5:00 p.m. Eastern time / 2:00 p.m. Pacific time to discuss the operating performance for the quarter. The conference call will be available live over the Internet at the investor relations section of Transmeta's website at www.transmeta.com. To listen to the conference call, please dial (913) 981-5546. A recording of the conference call will be available for one week, starting one hour after the completion of the call, until 9:59 p.m. Pacific time on November 15. The phone number to access the recording is (888) 203-1112, and the passcode is 2490167. For callers outside the U.S., please dial (719) 457-0820, with the same passcode.

About Transmeta Corporation

Transmeta Corporation develops and licenses innovative computing, microprocessor and semiconductor technologies and related intellectual property. Founded in 1995, Transmeta first became known for designing, developing and selling its highly efficient x86-compatible software-based microprocessors, which deliver a balance of low power consumption, high performance, low cost and small size suited for diverse computing platforms. We also develop advanced power management technologies for controlling leakage and increasing power efficiency in semiconductor and computing devices. To learn more about Transmeta, visit www.transmeta.com.

Safe Harbor Statement

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date of this release, and we will not necessarily provide updates of our projections or other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to many risks and uncertainties, and may differ materially or adversely from our actual results or future events. Important risk factors that could have material or adverse effects on our results include general economic and political co
[verwijderd]
0
Salieman
0
Gefeliciteerd allen!

Ik ga morgen ook kopen, hoop dat ik nog ergen in de 1 dollar iets kan kopen:)

Groeten
5.364 Posts, Pagina: « 1 2 3 4 5 6 ... 213 214 215 216 217 218 219 220 221 222 223 ... 265 266 267 268 269 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Direct naar Forum

Markt vandaag

AEX 903,61 -1,97 -0,22% 31 mei
AMX 922,59 -4,51 -0,49% 31 mei
ASCX 1.245,59 +5,37 +0,43% 31 mei
BEL 20 3.918,09 +9,38 +0,24% 31 mei
Germany40^ 18.585,90 +89,11 +0,48% 31 mei
US30^ 38.701,80 0,00 0,00% 31 mei
US500^ 5.280,42 0,00 0,00% 31 mei
Nasd100^ 18.538,90 0,00 0,00% 31 mei
Japan225^ 38.630,50 0,00 0,00% 31 mei
WTI 77,14 0,00 0,00% 31 mei
Brent 81,20 0,00 0,00% 31 mei
EUR/USD 1,0834 +0,0000 +0,00% 31 mei
BTC/USD 67.676,02 -768,97 -1,12% 14:43
Gold spot 2.327,41 0,00 0,00% 31 mei
#/^ Index indications calculated real time, zie disclaimer
BESTEL HIER UW TICKETS VOOR DE IEX BELEGGERSDAG > EEN DAG VOL INSPIRERENDE SPREKERS EN KOOPTIPS!

Stijgers & Dalers

Stijgers Laatst +/- % tijd
UMG 28,580 +0,530 +1,89% 31 mei
DSM FIRMENICH AG 105,650 +1,150 +1,10% 31 mei
ArcelorMittal 24,160 +0,250 +1,05% 31 mei
Dalers Laatst +/- % tijd
ASR Nederland 44,400 -2,280 -4,88% 31 mei
PROSUS 33,380 -0,795 -2,33% 31 mei
ASMI 640,200 -10,800 -1,66% 31 mei

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront